EP4074312
SIPONIMOD IMMEDIATE RELEASE DOSAGE REGIMEN FOR TREATING AUTOIMMUNE DISEASES
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
8.4.2015EP published:
25.2.2026EP application number:
21212400.2
EPO information:
European Patent Register
Max expiry date:
7.4.2035Expiry date:
24.6.2026
Title in English:
SIPONIMOD IMMEDIATE RELEASE DOSAGE REGIMEN FOR TREATING AUTOIMMUNE DISEASESLanguage of the patent:
English
Timeline
Today
8.4.2015EP application
25.2.2026EP Publication
24.6.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
Bouillot, Philippe Michel ReneAddress:
4002 Basel, CH
Name:
Dahlke, FrankAddress:
4002 Basel, CH
Name:
Legangneux, EricAddress:
4002 Basel, CH
Name:
Reynaud, EmericAddress:
4002 Basel, CH
Name:
Wallström, ErikAddress:
4002 Basel, CH
Priority
Number:
201461977816 PDate:
10.4.2014Country:
US
Classification
Categories:
A61K 31/397, A61K 9/20, A61P 21/00, A61P 25/28, A61P 37/00